A breakthrough in CD formulation has enabled researchers to evaluate the efficacy of oral thin films, ensuring both therapeutic efficacy and safety. NY, NEW YORK ...
Specialty pharma company Assertio Holdings has expanded its portfolio through a deal with Aquestive Therapeutics, paying $9 million upfront for exclusive rights to the Sympazan oral film formulation.
Mitsubishi Tanabe Pharma America and Aquestive Therapeutics announced a licensing and supply deal for U.S. rights to commercialize an oral film formulation of riluzole for the treatment of ALS, ...
VANCOUVER, BC / ACCESS Newswire / July 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
BALTIMORE, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address ...
Credit: IntelGenx. With RizaFilm oral films, administration with liquids is not necessary. The Food and Drug Administration (FDA) has approved RizaFilm ® (rizatriptan) oral film for the treatment of ...
VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback